Performance data is updated to 31 May 2026.
Vanguard International Shares High Yield ETF (VIHY) — Review & Analysis
VIHY is Vanguard's new global income ETF for Australian investors, with $40 million in assets as at May 2026. Vanguard launched VIHY on 25 March 2026 to give investors a passive, low-cost alternative to active global income products like Plato's PGI2 (0.85% MER) and Magellan's various global income vehicles. The management fee is 0.30% per annum — the cheapest global income ETF on the ASX by a wide margin. The fund tracks the FTSE All-World ex-Australia High Dividend Yield Index, targeting approximately 500-1,000 global companies forecast to pay above-average dividends.
To compare VIHY side-by-side with every other ETF on the ASX, see the full ETF directory.
VIHY's portfolio is structurally tilted toward financials, energy, telecoms and consumer staples — the sectors where dividend yields are highest. As at May 2026, expected top holdings include Procter & Gamble, JPMorgan Chase, Exxon Mobil, Johnson & Johnson, Roche, Nestle, Chevron, Cisco Systems, Pfizer and Verizon. Geographic exposure is approximately 50% US, with the remainder spread across the UK (where dividend yields are structurally higher), Switzerland, Japan, Canada and Europe — meaningfully more diversified than US-only income ETFs. Too new for meaningful return data.
VIHY pays distributions quarterly (late March, June, September and December) at a higher yield than broad global ETFs. The trailing 12-month yield is expected to run around 3.5-4.5% gross — well above the ~1.5% yield of VGS. There are no franking credits — the underlying holdings are international. VIHY is currency-unhedged. The 0.30% MER vs the typical 0.85-1.00% MER of active global income funds is a meaningful long-term cost saving — over 30 years on a $100k investment, the fee gap compounds to $50-80k.
VIHY fills a real gap on the ASX — there hasn't been a low-cost passive global income ETF before. It's well-positioned for retirees who want global diversification without sacrificing yield. Pair it with VHY (Australian high-yield) for a global income tilt. Caveat: the underlying high-yield strategy systematically picks slow-growing companies in mature sectors — VIHY will underperform broad-market global ETFs in growth-led rallies. For more on dividend strategies, see The ultimate list of dividend-paying ETFs on the ASX, ranked by 5-year data.
Performance (% return)

Investment Focus
Themes
Exposure Regions
Portfolio Breakdown
| Symbol | Company Name | % assets |
|---|---|---|
| JPM | JPMorgan Chase & Co | 2.04% |
| XOM | Exxon Mobil Corp | 1.79% |
| JNJ | Johnson & Johnson | 1.52% |
| CVX | Chevron Corp | 0.99% |
| ABBV | AbbVie Inc | 0.99% |
| PG | Procter & Gamble Co/The | 0.86% |
| HD | Home Depot Inc/The | 0.84% |
| BAC | Bank of America Corp | 0.83% |
| CSCO | Cisco Systems Inc | 0.79% |
| MRK | Merck & Co Inc | 0.76% |
Related Reads

Australia's Dividend ETFs Exposed 2026: VHY vs SYI vs IHD vs Every Other Income Fund
There are now 10 ETFs on the ASX competing for your dividend dollar. They all promise the same thing — high income from Australian shares. But over the past year, the gap between the best and worst is more than 30 percentage points. Some funds charge 4.5x more than others. And the headline yield issuers love to advertise can be deeply misleading.

High Dividend Yield & Income ETFs on the ASX: The 2026 Guide to Generating Passive Income
There are now 31 high-dividend and income ETFs on the ASX as at May 2026 — total assets around $18.6 billion, average MER 0.43%. They range from boring cash funds yielding ~4% to covered-call ETFs paying 9%+ headline yields that quietly erode your capital.
Similar ETFs
| Stock | Name | 1 Year % |
|---|---|---|
| CFLO | Global Cash Flow Kings ETF | +4.50% |
Disclaimer
The information provided on ReviewETF.com.au is intended for general information and comparison purposes only. It is compiled and presented on a best-endeavours basis from publicly available sources, but we do not guarantee its accuracy, completeness, timeliness, or suitability for any particular purpose.
No content on this website constitutes financial advice, investment recommendation, solicitation, or an offer to buy or sell any securities. Past performance is not indicative of future results, and all investments carry risk, including the potential loss of capital.
The point of truth for any ETF is always the official product disclosure statement (PDS), website, and announcements from the ETF issuer/provider (e.g., Vanguard, BetaShares, iShares, VanEck, etc.). We link directly to these primary sources on each individual ETF page wherever possible—please verify all details there before making any decisions.
ReviewETF.com.au, its owner (Joshua), and any associated entities disclaim all liability for any loss or damage arising from the use of, or reliance on, information contained on this site. Users should seek independent professional financial advice tailored to their personal circumstances.
This website may contain links to third-party sites; we are not responsible for their content or privacy practices.
Last updated: January 2026

